BEUDAMED
    FDA Adverse Event Injury Summary report: N

    KEEOGO-CLINICIAN KIT

    MDR report key: 23241275 · Received October 7, 2025

    Report

    Report Number
    3012602431-2025-00087
    Event Type
    Injury
    Date Received
    October 7, 2025
    Date of Event
    September 8, 2025
    Report Date
    October 7, 2025
    Manufacturer
    B-TEMIA
    Product Code
    PHL
    Adverse Event
    Yes
    Report Source
    Distributor report
    Reporter Location
    FR
    Reporter Occupation
    PHYSICIAN
    Health Professional
    Yes

    Narratives

    Additional Manufacturer Narrative · 0

    THE KEEOGO DERMOSKELETON INVOLVED IN THIS EVENT WAS INSPECTED ON SITE BY THE CLINICAL TEAM AND CONFIRMED TO BE FUNCTIONING PROPERLY BEFORE, DURING, AND AFTER THE INCIDENT. NO DEVICE MALFUNCTION, DEFECT, OR ABNORMAL BEHAVIOR WAS IDENTIFIED. THE ADVERSE EVENT WAS REPORTED TO THE FRENCH COMPETENT AUTHORITY (ANSM) ON 2025-09-18 BY THE MANUFACTURER (B-TEMIA) IN ACCORDANCE WITH EU MDR REQUIREMENTS. AT THIS STAGE, NO REMEDIAL ACTION OR FIELD SAFETY CORRECTIVE ACTION WAS INITIATED. THE PATIENT REMAINS HOSPITALIZED IN STABLE CONDITION. B-TEMIA WILL SUBMIT A SUPPLEMENTAL MDR ONCE ADDITIONAL CLINICAL INFORMATION BECOMES AVAILABLE FROM THE INVESTIGATIONAL SITE (E.G., PATIENT CARDIOVASCULAR HISTORY, CONCOMITANT MEDICATIONS, BASELINE VITAL SIGNS).

    Description of Event or Problem · 0

    ON (B)(6) 2025, DURING THE EXHOMESEP CLINICAL INVESTIGATION IN FRANCE (PROTOCOL ID-(B)(4), A 74-YEAR-OLD MALE. SUBJECT (PATIENT ID: (B)(6) WITH A PRE-EXISTING DIAGNOSIS OF PRIMARY PROGRESSIVE MULTIPLE SCLEROSIS EXPERIENCED ACUTE CARDIAC SYMPTOMS WHILE PERFORMING A SUPERVISED REHABILITATION EXERCISE SESSION WITH THE KEEOGO DERMOSKELETON SYSTEM. AT 15:00, THE SUBJECT DEVELOPED RETROSTERNAL CONSTRICTIVE CHEST PAIN RADIATING TO THE JAW AND LEFT ARM DURING THE SESSION. SYMPTOMS RESOLVED AFTER STOPPING THE EXERCISE. AT 20:00, CHEST PAIN RECURRED AT REST FOR ABOUT ONE HOUR, WITH BLOOD PRESSURE MEASURED AT 180 MMHG. ECG WAS INCONCLUSIVE. TROPONIN LATER TESTED POSITIVE (INCREASE FROM 10 NG/L TO 35 NG/L). ON (B)(6) 2025 AT 02:00, CHEST PAIN RECURRED AGAIN, REQUIRING ADMISSION TO THE CARDIOLOGY DEPARTMENT FOR SUSPECTED ANGINA/NSTEMI. THE EVENT WAS CLASSIFIED AS LIFE-THREATENING. THE PATIENT REMAINED HOSPITALIZED IN STABLE CONDITION AT THE TIME OF REPORTING. THE KEEOGO DEVICE WAS INSPECTED BY THE STUDY TEAM AND CONFIRMED TO BE FUNCTIONING PROPERLY BEFORE, DURING, AND AFTER THE INCIDENT, WITH NO DEFECT OR MALFUNCTION IDENTIFIED. THE INVESTIGATOR NOTED THE POSSIBILITY THAT THE PHYSICAL EFFORT REQUIRED WHILE USING THE DEVICE DURING EXERCISE MAY HAVE CONTRIBUTED TO THE EVENT. ECG: T WAVE INVERSION IN LEAD T AND AVL; SLIGHT ST DEPRESSION IN V4-V5. BIOLOGICAL RESULTS: POTASSIUM 3.5 MMOL/L; CREATININE 68 [?]MOL/L; EGFR 90 ML/MIN; TROPONIN 12 NG/L THEN 35 NG/L; WBC 6 G/L; HEMOGLOBIN 14.5 G/DL; PLATELETS 220 G/L. ECHOCARDIOGRAPHY: SEVERE HYPOKINESIA OF THE MID-TO-DISTAL INFEROLATERAL WALL, EXTENDING LATERALLY; FINDINGS COMPATIBLE WITH MYOCARDIAL ISCHEMIA. CLINICAL ASSESSMENT: CARDIOPULMONARY EXAM WITHOUT SIGNS OF HEART FAILURE. DATE OF CARDIOLOGY ADMISSION: (B)(6) 2025. PRE-EXISTING CONDITION: PRIMARY PROGRESSIVE MULTIPLE SCLEROSIS (PPMS). NO KNOWN CARDIOVASCULAR HISTORY PRIOR TO THE EVENT. RISK FACTORS: AGE, MALE SEX, SEDENTARY LIFESTYLE, HISTORY OF SMOKING CESSATION, FAMILY HISTORY (FATHER HAD MYOCARDIAL INFARCTION BEFORE AGE 50). NO CONCOMITANT MEDICATIONS REPORTED. CONCOMITANT THERAPY: SUPERVISED PHYSICAL REHABILITATION IN CENTER (STARTED (B)(6) 2025).

    Devices

    Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
    2610855 KEEOGO-CLINICIAN KIT KEEOGO DERMOSKELETON SYSTEM PHL B-TEMIA 5062601

    Patients

    Seq Age Sex Outcome Treatment
    1 74 YR Male Life Threatening| O| H| R NO CONCOMITANT MEDICATIONS REPORTED BY SITE| PHYSICAL REHAB THERAPY (SUPERVISED SESSION)